Soligenix, Inc. (SNGX): Price and Financial Metrics
SNGX Price/Volume Stats
| Current price | $2.95 | 52-week high | $19.20 |
| Prev. close | $3.08 | 52-week low | $1.83 |
| Day low | $2.92 | Volume | 48,200 |
| Day high | $3.00 | Avg. volume | 762,859 |
| 50-day MA | $3.49 | Dividend yield | N/A |
| 200-day MA | $4.98 | Market Cap | 7.40M |
SNGX Stock Price Chart Interactive Chart >
Soligenix, Inc. (SNGX) Company Bio
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
SNGX Price Returns
| 1-mo | -12.20% |
| 3-mo | -22.77% |
| 6-mo | -12.72% |
| 1-year | -70.21% |
| 3-year | -98.40% |
| 5-year | -99.12% |
| YTD | -75.65% |
| 2023 | -88.83% |
| 2022 | -31.55% |
| 2021 | -48.41% |
| 2020 | -11.72% |
| 2019 | 68.60% |
Continue Researching SNGX
Want to see what other sources are saying about Soligenix Inc's financials and stock price? Try the links below:Soligenix Inc (SNGX) Stock Price | Nasdaq
Soligenix Inc (SNGX) Stock Quote, History and News - Yahoo Finance
Soligenix Inc (SNGX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...